Summary
LexaGene Life Sciences CF Investors, Inc. is a $5,000,000 equity offering structured as a special purpose vehicle listed on DealMaker.
The securities are offered under Regulation CF.
Terms shown here are drawn from SEC filings and were captured by AltStreet on 2026-08-24. Figures are as disclosed at the time of the offering and are not updated for subsequent performance.
Disclosed Terms
- Offering amount
- $5,000,000
- Structure
- Spv
- Status
- Funding closed
- Exemption
- Regulation CF
- Launched
- 2023-10-31
- Closed
- 2024-10-31
Terms as disclosed at the time of the offering. AltStreet does not update these figures for subsequent performance, and a disclosed rate is not a realized return.
Filing Record
The issuer behind LexaGene Life Sciences CF Investors, Inc. files under Regulation Crowdfunding (Form C). Its offering chain runs from C on Oct 31, 2023 to C on Oct 31, 2023, 1 filing in all. AltStreet's status rule reads the chain as annual amendment overdue (no progress update or annual report 12+ months after the Form C).
From SEC EDGAR, as filed. Issuer filing history.
Terminal Analysis
Terminal analysis for this offering
Terminal access unlocks 4 comparable offerings side by side.
Access full researchQuestions About This Offering
What is LexaGene Life Sciences CF Investors, Inc.?
LexaGene Life Sciences CF Investors, Inc. is a $5,000,000 equity offering structured as a special purpose vehicle listed on DealMaker. The securities are offered under Regulation CF. Terms shown here are drawn from SEC filings and were captured by AltStreet on 2026-08-24. Figures are as disclosed at the time of the offering and are not updated for subsequent performance.
What do investors in LexaGene Life Sciences CF Investors, Inc. actually own?
Investors hold an interest in a special purpose vehicle listed on DealMaker, not direct shares of the underlying company — a structure with its own transfer, information, and fee implications.
Who is the issuer of LexaGene Life Sciences CF Investors, Inc.?
The offering relies on Regulation CF, which allows any investor to participate within annual limits.
When did LexaGene Life Sciences CF Investors, Inc. launch and close?
The offering launched on 2023-10-31. It closed on 2024-10-31. AltStreet records its status as funding closed.
Is LexaGene Life Sciences CF Investors, Inc. still open to investors?
AltStreet's record shows the offering as funding closed. AltStreet tracks this offering from SEC filings, last captured 2026-08-24. Offering status changes without a corresponding filing in many cases, so current availability should be confirmed directly with DealMaker before acting.
Related Offerings on DealMaker
Miso Robotics Regulation CF, offering 020-32679
Pre Ipo
Miso Robotics Regulation CF, offering 020-35461
Pre Ipo
Miso Robotics Regulation A, offering statement 024-12380
Pre Ipo
Miso Robotics Regulation A, offering statement 024-12613
Pre Ipo
BioXgen Holdings, Inc.
Longevity Biotech
Standard Carbon Technology Inc.
Carbon Climate
Legion M Film Fund - 1099, LLC
Digital Ip Royalties
American Rebel Licensing NIL I, Inc.
Digital Ip Royalties
EnergyX Regulation CF, offering 020-35069
Energy Transition
Coin & Card Auctions, Inc
Fine Art
Andrew Arroyo Real Estate Inc.
Real Estate
Virginia Beach Arena Corp
Real Estate
Rayton Solar Inc.
Energy Transition
Klondike Royalties II, LP
Mineral Rights
reAlpha 612 Jasmine Lane Inc.
Real Estate
CERLOS(R) Factory I, LLC
Energy Transition
Aquinas Senior Living, Inc.
Real Estate
United States Tungsten, LLC
Mineral Rights
Andrew Arroyo Real Estate Inc. (Reg A Tier 2 Offering)
Real Estate
Pre Ipo offerings on other platforms
Prophet Mortgage Servicing Opportunities (Onshore) LP
Robinhood Ventures
Excel Driver Services, LLC
Robinhood Ventures
EquityZen Growth Technology Fund LLC - Series 2398
EquityZen
Equitybee 22-42164, a Series of Equitybee cFund Master LLC
Equitybee
Equitybee 22-76200, a Series of Equitybee cFund Master LLC
Equitybee
EquityZen Growth Technology Fund LLC - Series 2387
EquityZen
Augment Collective, LLC Series Space and Defense II
Augment
Augment Collective, LLC Series Defense II
Augment
All DealMaker offerings →All pre ipo offerings →